BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1332097)

  • 1. Differential impact of naltrexone on luteinizing hormone release during single versus repetitive exposure to restraint stress.
    Briski KP; Sylvester PW
    Psychoneuroendocrinology; 1992; 17(2-3):125-33. PubMed ID: 1332097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endogenous opioid peptides in central glucocorticoid receptor (GR)-induced decreases in circulating LH in the male rat.
    Briski KP; Vogel KL
    Neuropeptides; 1995 Mar; 28(3):175-81. PubMed ID: 7791961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood luteinizing hormone and prolactin concentrations in response to naltrexone challenge: studies on rats with diabetes induced by different doses of streptozotocin.
    Yogev L; Yavetz H; Gottreich A; Oppenheim D; Homonnai ZT; Paz G
    Life Sci; 1994; 54(4):261-6. PubMed ID: 8289586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative feedback functions in chronically stressed rats: role of the posterior paraventricular thalamus.
    Jaferi A; Nowak N; Bhatnagar S
    Physiol Behav; 2003 Mar; 78(3):365-73. PubMed ID: 12676271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central opioid receptors mediate glucoprivic inhibition of pituitary LH secretion.
    Briski KP
    Am J Physiol; 1997 Apr; 272(4 Pt 1):E517-22. PubMed ID: 9142869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counteraction by naltrexone of stress-induced inhibition of TSH release: role of noradrenergic system.
    Briski K; Quigley K; Meites J
    Proc Soc Exp Biol Med; 1984 Nov; 177(2):354-9. PubMed ID: 6091150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of neurogenic and immune stressors on testosterone secretion in rats.
    Rivier C
    Neuroimmunomodulation; 2002; 10(1):17-29. PubMed ID: 12207160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diazepam attenuation of restraint stress-induced corticosterone levels is enhanced by prior exposure to repeated restraint.
    Kalman BA; Kim PJ; Cole MA; Chi MS; Spencer RL
    Psychoneuroendocrinology; 1997 Jul; 22(5):349-60. PubMed ID: 9279940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of repeated restraint stress on pulsatile lutenizing hormone secretion in female Fischer, Lewis and Wistar rats.
    Li XF; Edward J; Mitchell JC; Shao B; Bowes JE; Coen CW; Lightman SL; O'Byrne KT
    J Neuroendocrinol; 2004 Jul; 16(7):620-7. PubMed ID: 15214865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous opiate involvement in acute and chronic stress-induced changes in plasma LH concentrations in the male rat.
    Briski KP; Quigley K; Meites J
    Life Sci; 1984 Jun; 34(25):2485-93. PubMed ID: 6374352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone does not reverse the inhibitory effect of chronic restraint on gonadotropin secretion in the intact male rat.
    González-Quijano MI; Ariznavarreta C; Martín AI; Treguerres JA; López-Calderón A
    Neuroendocrinology; 1991 Nov; 54(5):447-53. PubMed ID: 1749459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulatory vs. inhibitory effects of acute stress on plasma LH: differential effects of pretreatment with dexamethasone or the steroid receptor antagonist, RU 486.
    Briski KP
    Pharmacol Biochem Behav; 1996 Sep; 55(1):19-26. PubMed ID: 8870033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the LH surge in cyclic rats by stress is not mediated by opioids.
    Roozendaal MM; Swarts JJ; van Maanen JC; Wiegant VM; Mattheij JA
    Life Sci; 1997; 60(10):735-42. PubMed ID: 9064478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiglucocorticoid, RU486, attenuates stress-induced decreases in plasma-luteinizing hormone concentrations in male rats.
    Briski KP; Vogel KL; McIntyre AR
    Neuroendocrinology; 1995 Jun; 61(6):638-45. PubMed ID: 7659189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central vasopressin V1A receptor blockade alters patterns of cellular activation and prevents glucocorticoid habituation to repeated restraint stress exposure.
    Gray M; Innala L; Viau V
    Int J Neuropsychopharmacol; 2014 Dec; 17(12):2005-15. PubMed ID: 24913767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orexin 2 receptor regulation of the hypothalamic-pituitary-adrenal (HPA) response to acute and repeated stress.
    Grafe LA; Eacret D; Luz S; Gotter AL; Renger JJ; Winrow CJ; Bhatnagar S
    Neuroscience; 2017 Apr; 348():313-323. PubMed ID: 28257896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of repetitive daily acute stress on pituitary LH and prolactin release during exposure to the same stressor or a second novel stress.
    Briski KP; Sylvester PW
    Psychoneuroendocrinology; 1987; 12(6):429-37. PubMed ID: 3441582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation by naltrexone of stress-induced changes in humoral immune responsiveness and gastric mucosal integrity in rats.
    Ray A; Mediratta PK; Sen P
    Physiol Behav; 1992 Feb; 51(2):293-6. PubMed ID: 1313589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteinizing hormone secretion as a response to a second naltrexone administration.
    Yogev L; Gottreich A; Homonnai ZT; Yavetz H; Paz GF
    Proc Soc Exp Biol Med; 1990 Oct; 195(1):22-5. PubMed ID: 2399258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Habituation to repeated restraint stress is associated with lack of stress-induced c-fos expression in primary sensory processing areas of the rat brain.
    Girotti M; Pace TW; Gaylord RI; Rubin BA; Herman JP; Spencer RL
    Neuroscience; 2006; 138(4):1067-81. PubMed ID: 16431027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.